Patients with a history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease should avoid Retatrutide
doi: 10.3390/IJMS25073812 28 ChenXZhaoPWangWGuoLPanQ
[6] Liraglutide (Victoza): 1.8 mg once daily for type 2 diabetes, and 3 mg once daily for chronic weight management (marketed as Saxenda)
Are you using a GLP-1 receptor agonist? Listen closely
The starting dose used in phase 2 clinical trials has been low, with a gradual, pre-specified dose-escalation schedule over subsequent weeks to improve tolerability
Quick Answer: GLP-1 injections can cause tiredness, classified as a common side effect affecting between 1 in 10 and 1 in 100 people, particularly at higher doses used for weight management